Understanding artemisinin-resistant malaria: what a difference a year makes.

Area of Science:

• Malariology
• Drug Resistance Studies
• Molecular Parasitology

Background:

• Artemisinin combination therapies (ACTs) are failing in Southeast Asia, jeopardizing malaria control and elimination.
• Understanding artemisinin resistance mechanisms is vital to prevent its spread to Africa.

Purpose of the Study:

• To review recent progress in understanding artemisinin resistance in Plasmodium falciparum.
• To inform future strategies for preventing the spread of resistance to Africa.

Main Methods:

• Review of international collaborations and research findings on artemisinin resistance.
• Analysis of genetic mutations (K13 SNPs), parasite behavior in vitro, and clinical outcomes.

Main Results:

• Artemisinin resistance is linked to slow parasite clearance, increased early-ring-stage survival, K13 gene mutations, specific genetic backgrounds, unfolded protein response, and altered PI3K activity.
• In Western Cambodia, K13 C580Y mutation is near fixation, leading to ACT failure in nearly half of patients.
• Dozens of K13 mutations are present at low frequency in Africa, with no current evidence of artemisinin resistance.

Conclusions:

• Urgent clinical and epidemiological studies are needed in Southeast Asia to halt resistance spread.
• Monitoring ACT efficacy and identifying alternative drug regimens are critical.
• Rapid advancement of new antimalarial compounds through trials is essential.